[PDF] Top 20 Gene expression-based risk score in diffuse large B-cell lymphoma.
Has 10000 "Gene expression-based risk score in diffuse large B-cell lymphoma." found on our website. Below are the top 20 most common "Gene expression-based risk score in diffuse large B-cell lymphoma.".
Gene expression-based risk score in diffuse large B-cell lymphoma.
... use large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma and displays heterogeneous clinical and molecular ...characteristics. In this study, high ... Voir le document complet
12
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.
... Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study ...clinical risk ... Voir le document complet
12
Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients.
... GE-based risk score and NRIP1 and TCF7 expression, kept prognostic ...NRIP1 gene, known as RIP140, is a nuclear receptor coregulator with important role in energy homeostasis and ... Voir le document complet
12
Role of ETS1 in the transcriptional network of diffuse large B cell lymphoma of the activated B cell-like type
... gained in up to a fourth of DLBCL cases [ 7 , 8 ...described in different malignancies of epithelial tissues such as melanoma, breast cancer, and prostate cancer [ 9 ...]. In healthy B cells, ... Voir le document complet
17
Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors.
... 2012). In association with melphalan, Panobinostat yielded a 33% overall response rate in a phase I study including 12 patients with relapsed/refractory MM (Offidani et al, ...response in relapsing ... Voir le document complet
39
Cytolytic T-cell response to the PASD1 cancer testis antigenin patients with diffuse large B-cell lymphoma
... the gene PASD1 on Xq28, is a member of the CT-X group of CTAs (Scanlan et al, ...distribution in normal tissue but expres- sion in a variety of haematological malignancies highlighted PASD1 as a ... Voir le document complet
12
Subcutaneous Rituximab-MiniCHOP compared with subcutaneous Rituximab-MiniCHOP plus Lenalidomide in diffuse large B-Cell lymphoma for patients age 80 years or older.
... center B-cell –like (GCB) and activated B-cell –like (ABC) subtypes, differs according to patient ...increase in the ABC subtype prevalence during the aging of patients with DLBCL has ... Voir le document complet
12
A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival
... outcome in lymphomas treated with CHOP and related regimens, has been investigated before the introduction of rituximab ...were based on analyses of rela- tively small study samples ...OS in the ... Voir le document complet
12
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
... that in fluence the amount of tumor cfDNA are partially ...IPI score but also MTV or TLG 12 ...mutations in cfDNA, compared to gDNA, had a high MTV, suggesting that cfDNA mutations more accurately ... Voir le document complet
14
Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients.
... a gene set overexpressed in leukemic cells of acute T-cell leukemia/lymphoma patients [13] and to be associated with chemotherapy cross-resistance and treatment outcome in childhood ... Voir le document complet
10
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
... which expression is associated with outcome in R-CHOP patients Cox models were used to analyze the correlation between TLDA gene expression levels and progression free survival or overall ...A ... Voir le document complet
23
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
... Research in context Evidence before this study We searched PubMed on August 15, 2017, with no date restrictions, for all original publications (ie, review articles were excluded) with the search terms “follicular ... Voir le document complet
35
Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
... the expression of IL-35 in human ...cells in the most frequent type of non- Hodgkin lymphoma among adults, diffuse large B-cell lymphoma (DLBCL), but not ... Voir le document complet
13
Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients
... Micallef IN et al. Vitamin D Insufficiency and Prognosis in Non-Hodgkin’s ...prognostic score predicts survival and identifies high-risk patients in diffuse ... Voir le document complet
12
Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma.
... Gene expression profiling studies revealed that DLBCL comprises two main subgroups displaying distinct molecu- lar gene signatures and clinical outcome: one subgroup, termed germinal-center ... Voir le document complet
3
An alternative way to look at diffuse large B-cell lymphoma : the impact of frequent engagement of ReIB NF-κB subunit on cell survival and patient outcome
... RelB expression has been reported in various solid cancers ...non-small cell lung cancers) and appears to correlate with tumor aggressiveness [ 51 – 55 ...subunit in the nucleus of prostate ... Voir le document complet
138
Long non-coding RNAs as molecular signatures for canine B-Cell lymphoma characterization
... DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene ...al. Gene set enrichment analysis: A knowledge-based approach ... Voir le document complet
12
Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk
... Anaplastic lymphoma kinase (ALK)– positive anaplastic large cell lymphoma (ALCL) constitutes an ideal model dis- ease to study tumor-specific immune re- ...involved in lymphomagen- ... Voir le document complet
6
Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
... cells in some older ...expressed in the HRS cells of cHL and not in ALCL cells [ 23 , 44 , 45 ...amplifications in cHL [ 46 ] and may thus lead to an overexpression of these chemokines ... Voir le document complet
17
BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.
... 32. Enis DR, Shepherd BR, Wang Y, et al. Induction, differentiation, and remodeling of blood vessels after transplantation of BCL2-transduced endothelial cells. Proc Natl Acad Sci U S A 2005; 102:425-30. 33. Enis DR, ... Voir le document complet
22
Sujets connexes